Regulatory & Legal

The ad-tech giant posted record revenue for 2025, but a weaker-than-expected forecast for early 2026 sent its stock tumbling. What's next?

Pennant Group posts record revenue and an aggressive 2026 outlook, but rapid expansion and regulatory headwinds present a complex path forward for the provider.

MiMedx reports record 2025 sales and a $100M buyback, but faces a major challenge from new Medicare reimbursement rules set to disrupt the wound care market.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

The Kentucky Derby operator posts record revenue and operational earnings, yet a 28% drop in quarterly net income reveals a complex story of growth and challenges.

With stellar clinical data and a full war chest, Terns is hitting the road to convince investors its leukemia drug, TERN-701, is a true disruptor.

Labour unions and students decry the Ford government's plan to shift OSAP from grants to loans, warning of crippling debt and reduced access to education.

Y Combinator-backed Coinrule now offers AI-driven trading for stocks and ETFs, entering a competitive market under the watchful eye of regulators.

With $125 million in hand, ClearThink 1 enters a recovering SPAC market, setting its sights on a transformative deal in the dynamic financial services sector.

A new bipartisan bill offers loan forgiveness to physical therapists who work in rural areas, aiming to fix critical healthcare shortages across America.

Timed with the World Cup, a new exhibition explores the untold stories of Chinese Canadian athletes who shaped Canada's identity and challenged its history.

New FieldReporter module replaces paper sign-ins with geolocated digital logs, promising real-time data integrity and proactive labor compliance.

After 100 years in a Vatican museum, a rare model dog sled returns to the Métis Nation, sparking a journey of cultural healing and reconciliation.

As CFO Jim Kelly retires, Orbia promotes Cristian Capellino, the architect of its finance modernization, ensuring strategic continuity and focus on growth.

New data reveals that early reading progress has flatlined, with only 57% of K-2 students on track, prompting urgent calls for data-driven intervention.

A private market index tracking tech giants like SpaceX surged nearly 200% in 14 months, raising questions about a new, exclusive tier of wealth creation.

A new economic study finds West Virginia's greyhound racing industry doesn't pay for itself, surviving on millions in subsidies with no net benefit to the state.

A new FDA-cleared device promises to make the removal of ruptured breast implants faster, cleaner, and safer, addressing a major concern for patients and surgeons.

Celebrating its 40th anniversary, the Ricordi® Chamber not only transformed diabetes research but now serves as the foundation for the future of cell therapy.